- Home
- IVA vs POWW Comparison
IVA vs POWW Comparison
Compare IVA & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- POWW
- Stock Information
- Founded
- IVA 2011
- POWW 1990
- Country
- IVA France
- POWW United States
- Employees
- IVA N/A
- POWW N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- POWW Ordnance And Accessories
- Sector
- IVA Health Care
- POWW Industrials
- Exchange
- IVA Nasdaq
- POWW Nasdaq
- Market Cap
- IVA 162.8M
- POWW 157.9M
- IPO Year
- IVA 2020
- POWW N/A
- Fundamental
- Price
- IVA $3.90
- POWW $1.78
- Analyst Decision
- IVA Strong Buy
- POWW Hold
- Analyst Count
- IVA 4
- POWW 1
- Target Price
- IVA $10.50
- POWW $1.50
- AVG Volume (30 Days)
- IVA 23.7K
- POWW 491.6K
- Earning Date
- IVA 03-26-2025
- POWW 06-12-2025
- Dividend Yield
- IVA N/A
- POWW N/A
- EPS Growth
- IVA N/A
- POWW N/A
- EPS
- IVA N/A
- POWW N/A
- Revenue
- IVA $14,591,573.00
- POWW $135,498,023.00
- Revenue This Year
- IVA $15.38
- POWW $5.67
- Revenue Next Year
- IVA $24.22
- POWW N/A
- P/E Ratio
- IVA N/A
- POWW N/A
- Revenue Growth
- IVA N/A
- POWW N/A
- 52 Week Low
- IVA $1.53
- POWW $0.95
- 52 Week High
- IVA $4.05
- POWW $2.86
- Technical
- Relative Strength Index (RSI)
- IVA 69.86
- POWW 69.12
- Support Level
- IVA $3.69
- POWW $1.24
- Resistance Level
- IVA $4.05
- POWW $1.38
- Average True Range (ATR)
- IVA 0.25
- POWW 0.11
- MACD
- IVA 0.07
- POWW 0.07
- Stochastic Oscillator
- IVA 86.96
- POWW 84.85
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About POWW AMMO Inc.
AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.